Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation Research

• Publication date

  2014-03-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.114.303312PMID 24425713PMCID PMC4185401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis.

  2013cited by this paper
• Cardiovascular disease in lupus: insights and updates

  2013cited by this paper
• Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis.

  2013cited by this paper
• Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State

  2013cited by this paper
• Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.

  2013influential reference
• Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides.

  2013cited by this paper
• Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides

  2013cited by this paper
• Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice

  2013cited by this paper
• Neutrophil extracellular traps promote deep vein thrombosis in mice

  2012cited by this paper
• Activation of PAD4 in NET formation

  2012cited by this paper
• Neutrophil extracellular trap (NET) impact on deep vein thrombosis.

  2012cited by this paper
• P-selectin glycoprotein ligand-1 deficiency leads to cytokine resistance and protection against atherosclerosis in apolipoprotein E deficient mice.

  2012cited by this paper
• Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.

  2012influential reference
• Lack of Neutrophil-Derived CRAMP Reduces Atherosclerosis in Mice

  2012cited by this paper
• Plasmacytoid Dendritic Cells Play a Key Role in Promoting Atherosclerosis in Apolipoprotein E–Deficient Mice

  2012cited by this paper
• Auto-Antigenic Protein-DNA Complexes Stimulate Plasmacytoid Dendritic Cells to Promote Atherosclerosis

  2012influential reference
• PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures

  2012cited by this paper
• Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones

  2012cited by this paper
• Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo

  2012cited by this paper
• Cardiovascular Risk in Rheumatoid Arthritis: Pathogenesis, Diagnosis, and Management

  2012cited by this paper
• Apolipoprotein E-knockout mice show increased titers of serum anti-nuclear and anti-dsDNA antibodies.

  2012cited by this paper
• Neutrophil extracellular traps: Is immunity the second function of chromatin?

  2012cited by this paper
• Multiple roles for neutrophils in atherosclerosis.

  2012cited by this paper
• Type I IFN system in the development and manifestations of SLE

  2012cited by this paper
• Presence of luminal neutrophil extracellular traps in atherosclerosis

  2012cited by this paper
• The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.

  2011cited by this paper
• N-α-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-l-Ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis

  2011cited by this paper
• Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus

  2011cited by this paper
• Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus

  2011cited by this paper
• Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus

  2011cited by this paper
• Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus.

  2011cited by this paper
• Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice.

  2011cited by this paper
• A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs

  2010cited by this paper
• Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions.

  2010cited by this paper
• Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis‐mediated cell death

  2010cited by this paper
• Extracellular DNA traps promote thrombosis

  2010cited by this paper
• Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis

  2010cited by this paper
• Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells

  2010cited by this paper
• An improved synthesis of haloaceteamidine-based inactivators of protein arginine deiminase 4 (PAD4).

  2008cited by this paper
• Visceral Adipose Tissue Inflammation Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice

  2008cited by this paper
• Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR−/− Mice

  2007cited by this paper
• Synergistic Proinflammatory Effects of the Antiviral Cytokine Interferon-&agr; and Toll-Like Receptor 4 Ligands in the Atherosclerotic Plaque

  2007cited by this paper
• Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.

  2006cited by this paper
• Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase.

  2005cited by this paper
• Mouse bone marrow contains large numbers of functionally competent neutrophils

  2004cited by this paper
• Neutrophil Extracellular Traps Kill Bacteria

  2004cited by this paper
• What is known

  2003cited by this paper
• L-Selectin Shedding Regulates Leukocyte Recruitment

  2001cited by this paper
• cDNA structures and regulation of two interferon-induced human Mx proteins

  1989cited by this paper

• Sex-specific effects of peptidyl arginine deiminase 4 deficiency in the cafeteria diet-induced obesity-associated metabolic complications

  2026cites this paper
• Neutrophil CAPNS1 regulates cardiac inflammation and injury by promoting NETosis in CVB3-induced myocarditis.

  2026cites this paper
• Neutrophil extracellular traps in atherothrombosis

  2026cites this paper
• Serum YB-1 links dyslipidemia to NET-mediated vascular calcification in hemodialysis

  2026cites this paper
• The effect of neutrophil extracellular traps in atherosclerosis.

  2026cites this paper
• Roles and mechanistic insights into bile acids in sepsis pathogenesis

  2026cites this paper
• CitH3, a Druggable Biomarker for Human Diseases Associated with Acute NETosis and Chronic Immune Dysfunction

  2025cites this paper
• [Design and inflammation-targeting efficiency assessment of an engineered liposome-based nanomedicine delivery system targeting E-selectin].

  2025cites this paper
• Targeting Neutrophil Extracellular Traps: A New Strategy for the Treatment of Acute Ischemic Stroke Based on Thrombolysis Resistance

  2025cites this paper
• The roles of neutrophils in cardiovascular diseases

  2025cites this paper
• Modified Lipid Particle Recognition: A Link Between Atherosclerosis and Cancer?

  2025cites this paper
• “The NET effect”: Neutrophil extracellular traps—a potential key component of the dysregulated host immune response in sepsis

  2025cites this paper
• CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance

  2025cites this paper
• Neutrophil Extracellular Traps–Associated RNA Impedes CD4+ Treg Differentiation by TLR7–IRF7 Axis in Ankylosing Spondylitis

  2025cites this paper
• Ginsenoside Rb1 mitigates atherosclerosis in part through modulating FTO-mediated m6A RNA modification in NETs-induced endothelial activation

  2025cites this paper
• The Role of Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Ovarian Cancer: New Insight and Future Perspectives.

  2025cites this paper
• Oxidation of hemoglobin to ferryl hemoglobin contributes to remodeling of the artery wall in abdominal aortic aneurysm

  2025cites this paper
• Leukocyte immunoglobulin‐like receptor B2 regulates atherosclerosis progression by modulating macrophage extracellular trap formation in foam macrophages through the PI3K‐AKT signaling pathway

  2025cites this paper
• Integration of single-cell RNA sequencing and spatial transcriptomics reveals neutrophil diversity and spatial heterogeneity in acute kidney injury.

  2025cites this paper
• Neutrophil extracellular traps in cardiovascular disease: a bibliometric analysis (2005–2024)

  2025cites this paper
• Heart of the matter: Neutrophils, cancer, and cardiovascular disease.

  2025cites this paper
• The Crosstalk Between NETs and the Complement Cascade: An Overview in Nephrological Autoimmune Disease

  2025cites this paper
• The Inflammasome-NETosis Axis: A Critical Pathway in Atherosclerosis Pathogenesis and Therapeutic Targeting

  2025cites this paper
• Neutrophil heterogeneity and plasticity: unveiling the multifaceted roles in health and disease

  2025cites this paper
• Exploring the Roles of Liver X Receptors in Lipid Metabolism and Immunity in Atherosclerosis

  2025cites this paper
• Inflammasome Activation and Neutrophil Extracellular Traps in Atherosclerosis

  2025cites this paper
• NETosis in diabetic kidney disease: Molecular mechanisms and therapeutic opportunities.

  2025cites this paper
• Melatonin Alleviates Periodontitis by Suppressing Neutrophil Extracellular Traps-Dependent Neutrophil Recruitment.

  2025cites this paper
• Ovarian cancer, neutrophil hitchhiking, and NETs: unraveling their role in pathogenesis and management

  2025cites this paper
• NETosis-specific cell death: a novel mechanism in the pathogenesis of gouty arthritis

  2025cites this paper
• NETosis in Alzheimer’s Disease: Understanding the Role of Neutrophil Extracellular Traps (NETs) in Neuroinflammation and Disease Pathogenesis

  2025cites this paper
• Neutrophil Extracellular Traps (NETs) in health and disease

  2025cites this paper
• Emerging molecular targets in deep vein thrombosis: from inflammation to coagulation

  2025cites this paper
• Neutrophil Extracellular Traps (NETs) as drivers of atherosclerosis: Pathogenic mechanisms and therapeutic opportunities.

  2025cites this paper
• Inflammation in atherosclerosis: Lessons and therapeutic implications.

  2025cites this paper
• Neutrophil Extracellular Traps Promote Platelet-Driven Contraction of Inflammatory Blood Clots via Local Generation of Endogenous Thrombin and Softening of the Fibrin Network

  2025cites this paper
• Cross-Talk Between Neutrophils and Macrophages Post-Myocardial Infarction: From Inflammatory Drivers to Therapeutic Targets

  2025cites this paper
• Engineered immune-driven theranostics for clinical cardiology

  2025cites this paper
• Neutrophil Hitchhiking‐Mediated Delivery of ROS‐Scavenging Biomimetic Nanoparticles for Enhanced Treatment of Atherosclerosis

  2025cites this paper
• Exploring Neutrophil Extracellular Traps in Cardiovascular Pathologies: The Impact of Lipid Profiles, PAD4, and Radiation

  2025cites this paper
• NETs: a new target for autoimmune disease

  2025cites this paper
• Neutrophils and NETosis in Alzheimer's disease: Unraveling pathogenic mechanisms and novel therapeutic targets.

  2025cites this paper
• Immunosuppressive microenvironment of liver restrains chemotherapeutic efficacy in triple-negative breast cancer

  2025cites this paper
• Extracellular cold-inducible RNA-binding protein in CNS injury: molecular insights and therapeutic approaches

  2025cites this paper
• NLRP3 inflammasome in cardiovascular diseases: an update

  2025cites this paper
• Role of platelets and NETs in arterial thrombosis

  2025cites this paper
• Is L‐Arginine an Appropriate Alternative for Conventional Anti‐Atherosclerotic Therapy?: A Comprehensive Review

  2025cites this paper
• Multifaceted roles of neutrophils in cardiac disease.

  2025cites this paper
• Pathological roles of NETs-platelet synergy in thrombotic diseases: From molecular mechanisms to therapeutic targeting.

  2025cites this paper
• Neutrophil Extracellular Traps in Cardiovascular and Aortic Disease: A Narrative Review on Molecular Mechanisms and Therapeutic Targeting

  2024influential citation
• Neutrophil Extracellular Traps and Respiratory Disease

  2024cites this paper
• The Role of Citrullination Modification in CD4+ T Cells in the Pathogenesis of Immune-Related Diseases

  2024cites this paper
• NETscape or NEThance: tailoring anti-cancer therapy.

  2024cites this paper
• A machine learning-based diagnostic model for myocardial infarction patients: Analysis of neutrophil extracellular traps-related genes and eQTL Mendelian randomization

  2024cites this paper
• Low shear stress exacerbates atherosclerosis by inducing the generation of neutrophil extracellular traps via Piezo1-mediated mechanosensation.

  2024cites this paper
• NETworking for Health and in Disease: Neutrophil Extracellular Traps in Pediatric Surgical Care

  2024cites this paper
• Significance of neutrophil extracellular traps-related gene in the diagnosis and classification of atherosclerosis

  2024cites this paper
• Neutrophils in Physiology and Pathology.

  2024cites this paper
• Neutrophil extracellular traps: a catalyst for atherosclerosis

  2024cites this paper
• Vascular damage in systemic lupus erythematosus

  2024cites this paper
• naRNA-LL37 composite DAMPs define sterile NETs as self-propagating drivers of inflammation

  2024cites this paper
• Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?

  2024cites this paper
• Platelets accelerate lipid peroxidation and induce pathogenic neutrophil extracellular trap release.

  2024cites this paper
• Neutrophil Extracellular Traps (NETs) as a Potential Target for Anti-Aging: Role of Therapeutic Apheresis

  2024cites this paper
• Neutrophils in cancer: dual roles through intercellular interactions

  2024cites this paper
• Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation

  2024cites this paper
• Neutrophil Extracellular Traps Participate in the Pathogenesis of Lupus Through S100A10‐Mediated Regulatory T‐Cell Differentiation and Functional Abnormalities

  2024cites this paper
• Neutrophil extracellular traps worsen clotting and neuroinflammation in cavernomas

  2024cites this paper
• Neutrophil extracellular traps in homeostasis and disease

  2024cites this paper
• Associations of NETs with inflammatory risk and clinical predictive value in large artery atherosclerosis stroke: a prospective cohort study

  2024cites this paper
• Turning Neutrophil Cell Death Deadly in Hypertensive Vascular Disease.

  2024cites this paper
• Local Drug Delivery Systems as Novel Approach for Controlling NETosis in Periodontitis

  2024cites this paper
• Association of Neutrophil Extracellular Traps burden with clinical and angiographic characteristics in patients with ST-elevation myocardial infarction.

  2024cites this paper
• Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: Unravelling complementary effects on acute myocardial infarction and metabolic syndrome

  2024cites this paper
• The Role of Thrombo-inflammation in Ischemic Stroke: Focus on the Manipulation and Clinical Application

  2024cites this paper
• Pathological mechanisms and crosstalk among various cell death pathways in cardiac involvement of systemic lupus erythematosus

  2024cites this paper
• The Significance of Endothelial Dysfunction in Long COVID-19 for the Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular Disease

  2024cites this paper
• The pivotal role of neutrophil extracellular traps in cardiovascular diseases: Mechanisms and therapeutic implications.

  2024cites this paper
• Neutrophils and extracellular traps in crystal-associated diseases.

  2024cites this paper
• Autoimmune diseases and atherosclerotic cardiovascular disease

  2024cites this paper
• Elevated neutrophil extracellular trap levels in periodontitis: Implications for keratinization and barrier function in gingival epithelium.

  2024cites this paper
• Neutrophil extracellular traps in cancer

  2024cites this paper
• Targeting extranuclear histones to alleviate acute and chronic inflammation.

  2024cites this paper
• PAD inhibition downregulates the cellular fibrotic behavior of senescent myofibroblasts derived from dilated cardiomyopathy.

  2024cites this paper
• Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases

  2024cites this paper
• Moonlighting chromatin: when DNA escapes nuclear control

  2023cites this paper
• Neutrophil Extracellular Traps and NLRP3 Inflammasome: A Disturbing Duo in Atherosclerosis, Inflammation and Atherothrombosis

  2023cites this paper
• Roles of PADI4 in the expression of cytokines involved in inflammation and adhesion in differentiated NB4 cells treated with ATRA.

  2023cites this paper
• Antioxidant Strategies to Modulate NETosis and the Release of Neutrophil Extracellular Traps during Chronic Inflammation

  2023cites this paper
• The Role of Neutrophils in Lower Limb Peripheral Artery Disease: State of the Art and Future Perspectives

  2023cites this paper
• Platelet–Neutrophil Crosstalk in Thrombosis

  2023cites this paper
• Neutrophil extracellular trap stabilization by platelet factor 4 reduces thrombogenicity and endothelial cell injury

  2023cites this paper
• Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?

  2023cites this paper
• Neutrophil extracellular traps (NETs) in cardiovascular diseases: From molecular mechanisms to therapeutic interventions.

  2023cites this paper
• Worsening Thrombotic Complication of Atherosclerotic Plaques Due to Neutrophils Extracellular Traps: A Systematic Review

  2023cites this paper
• Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic mice

  2023cites this paper
• Platelet factor 4 limits neutrophil extracellular trap– and cell-free DNA–induced thrombogenicity and endothelial injury

  2023cites this paper
• Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice

  2023cites this paper
• Protein citrullination: inhibition, identification and insertion

  2023cites this paper
• Top Five Stories of the Cellular Landscape and Therapies of Atherosclerosis: Current Knowledge and Future Perspectives

  2023cites this paper